|
Volumn 18, Issue 6, 2013, Pages 773-774
|
Does reduced creatine synthesis protect against statin myopathy?
|
Author keywords
[No Author keywords available]
|
Indexed keywords
CREATINE;
CREATINE PHOSPHATE;
GLYCINE AMIDINOTRANSFERASE;
SIMVASTATIN;
AMINO ACID SYNTHESIS;
DRUG EXPOSURE;
DRUG INDUCED DISEASE;
GENE EXPRESSION;
GENETIC SUSCEPTIBILITY;
GENETIC VARIABILITY;
GENOTYPE;
HUMAN;
LYMPHOBLASTOID CELL LINE;
MYOPATHY;
PRIORITY JOURNAL;
QUANTITATIVE TRAIT LOCUS;
REVIEW;
SINGLE NUCLEOTIDE POLYMORPHISM;
STATIN MYOPATHY;
AMIDINOTRANSFERASES;
GENE EXPRESSION REGULATION;
HUMANS;
HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS;
MUSCULAR DISEASES;
QUANTITATIVE TRAIT LOCI;
SIMVASTATIN;
|
EID: 84889631687
PISSN: 15504131
EISSN: 19327420
Source Type: Journal
DOI: 10.1016/j.cmet.2013.11.012 Document Type: Short Survey |
Times cited : (14)
|
References (10)
|